nstudies | ncomp | d | 95% CI | Z | Q | I2 | P-valueg | NNT | |
---|---|---|---|---|---|---|---|---|---|
All studies | 20 | 20 | 0.31 | 0.17 to 0.45 | 4.25d | 34.91b | 45.58 | 5.75 | |
One effect per study (highest) | 15 | 15 | 0.30 | 0.13 to 0.48 | 3.47c | 30.35c | 53.88 | 5.95 | |
One effect per study (lowest) | 15 | 15 | 0.25 | 0.09 to 0.41 | 3.10c | 27.08b | 48.30 | 7.14 | |
BDI only | 10 | 14 | 0.43 | 0.22 to 0.64 | 4.07d | 26.30b | 50.57 | 4.20 | |
HAM-D only | 7 | 7 | 0.49 | 0.30 to 0.68 | 5.11d | 5.34, ns | 0 | 3.68 | |
Subgroup analyses | |||||||||
Recruitmentf | |||||||||
Referral | 7 | 11 | 0.43 | 0.28 to 0.58 | 5.75d | 9.71, ns | 0 | b | 4.20 |
Screening | 6 | 7 | 0.13 | −0.08 to 0.34 | 1.23 | 9.82, ns | 38.89 | 13.51 | |
Diagnosis | |||||||||
MDD | 7 | 10 | 0.21 | −0.00 to 0.42 | 1.95e | 19.15b | 53.00 | ns | 8.47 |
Other | 7 | 10 | 0.40 | 0.23 to 0.56 | 4.61d | 11.12, ns | 19.09 | 4.50 | |
Type of treatmenth | |||||||||
CBT | 7 | 9 | 0.42 | 0.22 to 0.62 | 4.16d | 9.72, ns | 17.67 | ns | 4.27 |
PST | 5 | 5 | 0.19 | −0.15 to 0.53 | 1.08, ns | 9.77b | 59.05 | 9.43 | |
Other | 5 | 6 | 0.27 | 0.04 to 0.49 | 2.35b | 9.65e | 48.20 | 6.58 | |
Number of sessionsh | |||||||||
≤6 | 7 | 9 | 0.25 | 0.02 to 0.48 | 2.12b | 16.56b | 51.68 | ns | 7.14 |
≥7 | 8 | 11 | 0.36 | 0.17 to 0.54 | 3.75d | 17.34e | 42.34 | 5.00 | |
Control group | |||||||||
Care-as-usual | 10 | 13 | 0.29 | 0.14 to 0.43 | 3.87d | 15.88, ns | 24.45 | ns | 6.17 |
Other | 5 | 7 | 0.40 | 0.07 to 0.73 | 2.39b | 18.73c | 67.97 | 4.50 | |
Analyses | |||||||||
Intention-to-treat | 10 | 10 | 0.23 | 0.05 to 0.42 | 2.47b | 23.18c | 61.18 | e | 7.69 |
Completers-only | 5 | 10 | 0.47 | 0.27 to 0.68 | 4.48d | 6.53, ns | 0 | 3.85 | |
Country | |||||||||
UK | 8 | 12 | 0.45 | 0.28 to 0.62 | 5.19d | 15.09, ns | 27.09 | b | 4.00 |
US | 5 | 6 | 0.11 | −0.15 to 0.38 | 0.84, ns | 10.01e | 50.03 | 16.13 | |
NL | 2 | 2 | 0.10 | −0.15 to 0.35 | 0.81, ns | 0.50, ns | 0 | 17.86 |
↵a According to the random effects model.
↵b P<0.05.
↵c P<0.01.
↵d P<0.001.
↵e P<0.1.
↵f In two studies information about how patients were screened was insufficient.
↵g The P-value indicates whether the difference between subgroups is significant.
↵h The total number of studies is larger than 15 because some studies examined more than one type of psychothery.
ncomp = number of comparisons. d = standardised mean difference. Q = indicator of homogeneity. I2 = indicator of heterogeneity in percentages. NNT = numbers-needed-to-treat. BD I = Beck Depression Inventory. HAM-D = Hamilton Rating Scale for Depression. MDD = major depressive disorder. CBT = cognitive behavioural therapy. PST = problem solving therapy. NL = the Netherlands.